Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Switch to Ticagrelor in Critical Limb Ischemia
NCT02091921Phase 2Completed
- Sponsor
- University of Southern California
- Start
- Feb 2014
- Primary completion
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ticagrelor in critical limb ischemia (CLI), sponsored by University of Southern California. Primary endpoint: Platelet Inhibition Before and After Switching for Two Weeks From Clopidogrel to Ticagrelor at 2 weeks. Started Feb 2014; status: completed.
02
Drugs
ticagrelor
03
Conditions
critical limb ischemia (CLI)
Beyond the preview
Go deeper on NCT02091921.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02091921.